What is NEUROFIBROMATOSIS type 1 and type 2

• SHARE NOW |
• Tweet Opens in a new window.
• Pin it Opens in a new window.
• Share Opens in a new window.
• Share Opens in a new window.
• Email Opens in a new window.

---

Understanding Neurofibromatosis: NF1 vs. NF2

Neurofibromatosis refers to a group of genetic conditions known as neurocutaneous disorders. These conditions cause tumors to form on nerve tissue throughout the body, including the brain, spinal cord, and peripheral nerves.

While they share a similar name, Neurofibromatosis Type 1 (NF1) and Neurofibromatosis Type 2 (NF2) are distinct disorders caused by mutations in different genes on different chromosomes.

Core Genetics: Inheritance & Mutations

Both NF1 and NF2 follow an Autosomal Dominant inheritance pattern. This means:

• Genetic Requirement: Only one copy of the altered gene is sufficient for the disorder to manifest (phenotypic expression).

• Inheritance Risk: Individuals with an affected parent have a 50% chance of inheriting the gene.

• De Novo Mutations: Many cases result from spontaneous mutations occurring for the first time in germ cells, appearing in families with no prior history.

NF1 vs. NF2: A Comparison

Feature	Neurofibromatosis Type 1 (NF1)	Neurofibromatosis Type 2 (NF2)
Gene Locus	Chromosome 17	Chromosome 22
Protein Product	Neurofibromin	Merlin (Schwannomin)
Primary Onset	Typically diagnosed in childhood.	Usually diagnosed in early adulthood.
Clinical Signs	Café-au-lait spots, Lisch nodules in the eye, and neurofibromas.	Hearing loss (acoustic neuroma), tinnitus, and balance issues.

The Science of Tumor Suppression

The genes associated with NF1 and NF2 produce proteins that act as "brakes" on cell growth.

• Dysregulation: When these genes are mutated, they produce abnormal gene products that cannot effectively regulate cell division.

• Tumor Formation: This failure in the tumor suppression mechanism leads to the characteristic nerve tumors found in both conditions.

Genetic Testing at Mapmygenome

Early diagnosis is crucial for the effective management of Neurofibromatosis. Mapmygenome offers comprehensive genetic testing to identify specific mutations in the $NF1$ and $NF2$ genes.

Testing can help you:

• Confirm a Clinical Diagnosis: Especially in early-onset cases where symptoms may be subtle.

• Understand Inheritance: Assess the risk for future generations and aid in family planning.

• Personalized Management: Gain insights that allow healthcare providers to create a proactive monitoring plan.

Take the first step toward clarity. Explore our clinical genomics portfolio to learn how genetic insights can empower your health journey.

References & Further Reading

• GeneReviews (NCBI): NF1 Management | NF2 Management

• OMIM Database: NF1 Gene #162200 | NF2 Gene #101000

• Children’s Tumor Foundation (CTF): Patient Resources

•